
|Videos|January 10, 2020
Targeting CD38 in Patients With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
An Early Look at EHA 2026: 10 Key Studies Heading to Stockholm
2
Dr Hurvitz on Gedatolisib's Superior Efficacy in PIK3CA+ Breast Cancer
3
ASCO 2026 GI Cancer Highlights: Beyond the LBAs
4
May 2026: FDA Oncology Actions at a Glance
5








































